Atopic dermatitis

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The cutaneous inflammatory disease remains perhaps the greatest therapeutic challenge in dermatology in terms of prevalence, symptomatic severity and recalcitrance. Atopic dermatitis (AD), nearly 90 years since its first comprehensive description, remains a confused composite of proposed pathomechanisms. This report will examine some of the current hypotheses relating to pathogenesis and possible therapeutic targeting.

Original languageEnglish (US)
Pages (from-to)36-38
Number of pages3
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume43
Issue numberSUPPL. 8
StatePublished - 1988

Fingerprint

Atopic Dermatitis
Dermatology
Skin Diseases
Therapeutics

ASJC Scopus subject areas

  • Immunology

Cite this

Atopic dermatitis. / Hanifin, Jon.

In: Allergy: European Journal of Allergy and Clinical Immunology, Vol. 43, No. SUPPL. 8, 1988, p. 36-38.

Research output: Contribution to journalArticle

@article{bf8958009aff46c3b478d04f299a5d42,
title = "Atopic dermatitis",
abstract = "The cutaneous inflammatory disease remains perhaps the greatest therapeutic challenge in dermatology in terms of prevalence, symptomatic severity and recalcitrance. Atopic dermatitis (AD), nearly 90 years since its first comprehensive description, remains a confused composite of proposed pathomechanisms. This report will examine some of the current hypotheses relating to pathogenesis and possible therapeutic targeting.",
author = "Jon Hanifin",
year = "1988",
language = "English (US)",
volume = "43",
pages = "36--38",
journal = "Allergy: European Journal of Allergy and Clinical Immunology",
issn = "0108-1675",
publisher = "Wiley-Blackwell",
number = "SUPPL. 8",

}

TY - JOUR

T1 - Atopic dermatitis

AU - Hanifin, Jon

PY - 1988

Y1 - 1988

N2 - The cutaneous inflammatory disease remains perhaps the greatest therapeutic challenge in dermatology in terms of prevalence, symptomatic severity and recalcitrance. Atopic dermatitis (AD), nearly 90 years since its first comprehensive description, remains a confused composite of proposed pathomechanisms. This report will examine some of the current hypotheses relating to pathogenesis and possible therapeutic targeting.

AB - The cutaneous inflammatory disease remains perhaps the greatest therapeutic challenge in dermatology in terms of prevalence, symptomatic severity and recalcitrance. Atopic dermatitis (AD), nearly 90 years since its first comprehensive description, remains a confused composite of proposed pathomechanisms. This report will examine some of the current hypotheses relating to pathogenesis and possible therapeutic targeting.

UR - http://www.scopus.com/inward/record.url?scp=0023778755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023778755&partnerID=8YFLogxK

M3 - Article

C2 - 2849327

AN - SCOPUS:0023778755

VL - 43

SP - 36

EP - 38

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

SN - 0108-1675

IS - SUPPL. 8

ER -